SlideShare a Scribd company logo
Presenter : Ravi Bhardwaj
Moderator: Anupam Sibal
Panelists : BR Thapa, Harshad Devarbhavi,
RK Dhiman, Srinivas Sankaranarayanan
Case Discussion
Acute liver failure with hemolysis
– needing a transplant
Dr Ravi Bharadwaj
FNB Pediatric Gastroenterology
Apollo Center For Advanced Pediatrics
Indraprastha Apollo Hospital
Presenting complaints
10 year old
Female
Presented in June 2016 with c/o:
Poor appetite with nausea
Fatigability
Progressive abdominal distension
Symptoms for 4 weeks
Took medicines from nearby practitioner
5th week of illness
Two episode of cola colored urine
painless
A day later parents noticed yellowish discoloration
of eyes
Decreased urine output
No documented fever
No diarrhea/abdominal pain/vomiting
No skin lesions/joint pain/joint swelling/chest pain
No dysuria/edema/pustules
No significant drug history
No bleeding from any site (skin, GI)
No seizures/alteration in sensorium/abnormal
movements/behavioural changes
Question?
Differential diagnosis?
Past History
No history of blood transfusion
No similar history in past
No history of prior admission for any illness
Developmentally normal
Vaccinated for age
Family history
One younger male sibling – 7 years, well
no history of similar illness in family
No h/o consanguinity
Dietary history: Calories 90 Cal/kg/day
Protein 1.5 g/kg/day
Admitted in nearby hospital
Evaluated and referred for further evaluation
On examination
RR: 26/min
Pulse: 96/min
Temp: 98.3 F
BP: 116/70mm Hg
SPO2: 96%
Weight: 25 kg (-1 to -2 SD)
Height: 128 cms ( -1 to -2 SD )
Pallor +, Icterus +
No clubbing/spider nevi/palmar erythema
Periorbital puffiness +
P/A: distended, soft
Liver 2 cms BCM/span 10 cms, firm with sharp
margins
Spleen 2 cms BCM, firm
FF+
CVS – WNL
Chest – no added sounds
CNS – WNL
Question?
Differential diagnosis?
Question?
How should this child be investigated further?
Investigations Investigations
Hb 8.3 Bil T/D 19.6/10.2
TLC 13100 P32L63 AST/ALT 670/214
Platelet count 113000 GGT 42
Peripheral
smear
normocytes, few
schistocytes
Fragmented RBC’s
ALP 47
ESR 21 mm/hr Prot/Albumin 7.3/3.5
Retic count 7% (corrected) PT/INR 3.7
DCT negative BU/Cr 54/1.1
Urine R/M Positive for Hb
Protein 1 +
Uric acid 1.1
LDH 886
Cultures sterile USG abdomen Coarse liver,
spleen enlarged,
mild ascites
Investigations
Anti-HAV IgM and total NR
HBsAg NR
Anti-HCV NR
Ceruloplasmin 8 mg/dl
24 Hr Urinary Copper (without
challenge)
413 mcg/day
KF ring positive
ANA negative
Score 7 on WD criteria (Leipzig score) by Ferenci et al
Serum Cp <10 mg/dl +2
Urine Cu > 2 ULN +2
KF ring +2
Coomb’s negative hemolytic anemia +1
Wilson's disease ( score > 4)
Acute Liver Failure in WD
Modest rises in serum aminotransferases (<< 2000 IU/L)
Normal or markedly subnormal SAP
AST/ALT >2.2 and ALP/Bil <4
Coombs (–) hemolytic anemia and hemolysis
Rapid progression to renal failure
Korman J et al. Hepatology 2008
Ferenci et al. Aliment Pharmacol Ther 2004
Roberts et al. AASLD. Hepatology 2008
EASL. J Hepatol 2012
D3 of admission
developed altered sensorium
drowsy
hyperreflexia
Question?
Is the diagnosis of Wilson’s disease confirmed?
Acute liver failure with grade 2 encephalopathy with
coombs negative hemolysis with AKI
Wilson’s disease
Prognostication
ALF without encephalopathy
Modified Nazer score
New wilson’s index
? PELD/MELD
Devarbhavi H et al. J Gastro Hepatol 2014
Nazer score
Nazer et al. Gut 1986
Score Bilirubin
ɥmol/L
INR AST
IU/L
WCC
x 109/L
Albumin
g/L
0 0-100 0-1.29 0-100 0-6.7 >45
1 101-150 1.3-1.6 101-150 6.8-8.3 34-44
2 151-200 1.7-1.9 151-300 8.4-10.3 25-33
3 201-300 2.0-2.4 301-400 10.4-15.3 21-24
4 >301 >2.5 >401 >15.4 <20
Modified King’s score (New Wilson Index)
A score ≥ 11 urgent need for transplantation
Our patient had a score of 16
Dhawan et al. Liver Transpl 2005
Multivariate analysis
Unadjusted hazard 95% Confidence P
Ratio Interval Value
Enc 2.88 1.11 – 7.45 .03
T Bil 1.05 1.02 – 1.09 .002
Only encepaholopaty and total bilirubin emerged as
independent predictors of mortality
Devarbhavi H. J Gastro Hepatol 2014
Score = 2.87 x encephalopathy + 1.07 x t bilirubin
ALF with encephalopathy
High mortality 80% (90% to 100% in some series)
Liver transplantation is lifesaving
Berman et al. Gastroenterology 1991
Roberts et al. AASLD. Hepatology 2008
EASL. J Hepatol 2012
Devarbhavi H et al. J Gastro Hepatol 2014
Question?
Treatment options in Wilsonian acute liver failure?
Child was taken for LRLT
Mother was donor
Question?
Donor evaluation/parents as donor in such cases
Sibling evaluation
First-degree relatives of any patient newly diagnosed
with WD must be screened
Chance of a sibling being a homozygote and therefore
developing clinical disease – is 25%
Analysis of the ATP7B gene for mutations in the
children
Roberts et al. AASLD. Hepatology 2008
EASL. J Hepatol 2012
POD # 1
post LT on POD#1
sensorium improved over the next 72 hours
Investigations
Hb 7.9
TLC 8100 P52L43
Platelet count 87000
Bil T/D 5.6/3.2
AST/ALT 220/114
ALP 83
Prot/Albumin 6.1/2.9
PT/INR 1.3
BU/Cr 21/0.6
POD#4
Child discharged on POD #19
On tacrolimus, MMF and prednisolone
No acute post-LT complications
Steroids tapered and stopped by 3 months
Question?
Role of supportive therapy, plasmapheresis,
hemodialysis and MARS
Neuro Wilson
Less common in children
< 10 years old: neuro-psychiatric disorders 17%
Average age of neurological dysfunction is 18.9 years
In adults neurological dysfunction constitutes initial
clinical manifestation in 40–60%
Pfeiffer et al. Semin Neurol. 2007
LT in treatment of progressive neurological
deterioration is controversial
Pfeiffer et al. Semin Neurol. 2007
Question
Role of LT in neuro Wilson?
Post LT outcome
Indication N/% Survival
@1 year
5 year 10 year 15 year
EHBA 66.1% 91.3 89.5 86.9 84.8
ALF 72.6 69 67 67
WD: Japan 2.6% 98.3 96.5 94.4 73.4
UNOS 90 89
SPLIT 96 91.4
France 89% 87% 87% 87%
Arnon et al. Clin Transplant. 2011
Kasahara et al. Am J of Transpl 2013
Guillaud et al. J Hepatol. 2014
LT experience
Pediatric 220
BA 81
Metabolic liver diseases 54
Cryptogenic 34
ALF 19
BCS 08
NNH 06
AIH 03
Hep B 03
Hyper oxaluria 02*
Poisoning 02
Hepatoblastoma 02
PVT 01**
Hep C 01
HCC 01
Chronic rejection 01
* combined LK
** re transplant
Thank you!

More Related Content

What's hot

Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
NephroTube - Dr.Gawad
 
Dr Jefferies Fabry and the Heart update
Dr Jefferies Fabry and the Heart updateDr Jefferies Fabry and the Heart update
Dr Jefferies Fabry and the Heart update
Fabry Support & Information Group
 
Kidney transplantation outcome complication chaken
Kidney transplantation outcome complication chakenKidney transplantation outcome complication chaken
Kidney transplantation outcome complication chaken
CHAKEN MANIYAN
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
NephroTube - Dr.Gawad
 
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El KosiLupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
MNDU net
 
Treatment of MPGN , What is the evidence?
Treatment of  MPGN , What is the evidence?Treatment of  MPGN , What is the evidence?
Treatment of MPGN , What is the evidence?
Mohamed E. Elrggal
 
10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis
MNDU net
 
Gn master class
Gn master classGn master class
Gn master class
FarragBahbah
 
ALL presentation -Dhaka Shishu Hospital
ALL presentation -Dhaka Shishu HospitalALL presentation -Dhaka Shishu Hospital
ALL presentation -Dhaka Shishu Hospital
shukur ullah echo
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
NephroTube - Dr.Gawad
 
Noon conference template ce-9-27
Noon conference template  ce-9-27Noon conference template  ce-9-27
Noon conference template ce-9-27
Virginia Mason Internal Medicine Residency
 
Clinical, endocrine &amp; genetic spectrums of mucopolysaccharidoses type v...
Clinical, endocrine &amp; genetic spectrums of   mucopolysaccharidoses type v...Clinical, endocrine &amp; genetic spectrums of   mucopolysaccharidoses type v...
Clinical, endocrine &amp; genetic spectrums of mucopolysaccharidoses type v...
Azad Haleem
 
Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE
Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE
Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE
Centre Hepato-Biliaire / AP-HP Hopital Paul Brousse
 
Fabry Disease Research Update - 14 February 2014
Fabry Disease Research Update - 14 February 2014Fabry Disease Research Update - 14 February 2014
Fabry Disease Research Update - 14 February 2014
Fabry Support & Information Group
 
Pain in Fabry Disease - 14 February 2014
Pain in Fabry Disease - 14 February 2014Pain in Fabry Disease - 14 February 2014
Pain in Fabry Disease - 14 February 2014
Fabry Support & Information Group
 
Approach to thalassemia with abdominal distension in children
Approach to thalassemia  with abdominal distension in childrenApproach to thalassemia  with abdominal distension in children
Approach to thalassemia with abdominal distension in children
Varsha Shah
 
Kawasaki Disease
Kawasaki DiseaseKawasaki Disease
Kawasaki Disease
DJ CrissCross
 
Management of liver failure
Management of liver failureManagement of liver failure
Management of liver failure
Apollo Hospitals
 
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTINGKIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
Dr Mayank Mohan Agarwal
 

What's hot (20)

Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
 
Dr Jefferies Fabry and the Heart update
Dr Jefferies Fabry and the Heart updateDr Jefferies Fabry and the Heart update
Dr Jefferies Fabry and the Heart update
 
Kidney transplantation outcome complication chaken
Kidney transplantation outcome complication chakenKidney transplantation outcome complication chaken
Kidney transplantation outcome complication chaken
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
 
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El KosiLupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
 
Treatment of MPGN , What is the evidence?
Treatment of  MPGN , What is the evidence?Treatment of  MPGN , What is the evidence?
Treatment of MPGN , What is the evidence?
 
10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis
 
Gn master class
Gn master classGn master class
Gn master class
 
ALL presentation -Dhaka Shishu Hospital
ALL presentation -Dhaka Shishu HospitalALL presentation -Dhaka Shishu Hospital
ALL presentation -Dhaka Shishu Hospital
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
 
Noon conference template ce-9-27
Noon conference template  ce-9-27Noon conference template  ce-9-27
Noon conference template ce-9-27
 
Clinical, endocrine &amp; genetic spectrums of mucopolysaccharidoses type v...
Clinical, endocrine &amp; genetic spectrums of   mucopolysaccharidoses type v...Clinical, endocrine &amp; genetic spectrums of   mucopolysaccharidoses type v...
Clinical, endocrine &amp; genetic spectrums of mucopolysaccharidoses type v...
 
Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE
Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE
Les hépatites auto-immunes - Jean-Charles DUCLOS-VALLEE
 
Fabry Disease Research Update - 14 February 2014
Fabry Disease Research Update - 14 February 2014Fabry Disease Research Update - 14 February 2014
Fabry Disease Research Update - 14 February 2014
 
Pain in Fabry Disease - 14 February 2014
Pain in Fabry Disease - 14 February 2014Pain in Fabry Disease - 14 February 2014
Pain in Fabry Disease - 14 February 2014
 
HCV Tx Update 2012 Townshend
HCV Tx Update 2012 TownshendHCV Tx Update 2012 Townshend
HCV Tx Update 2012 Townshend
 
Approach to thalassemia with abdominal distension in children
Approach to thalassemia  with abdominal distension in childrenApproach to thalassemia  with abdominal distension in children
Approach to thalassemia with abdominal distension in children
 
Kawasaki Disease
Kawasaki DiseaseKawasaki Disease
Kawasaki Disease
 
Management of liver failure
Management of liver failureManagement of liver failure
Management of liver failure
 
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTINGKIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
 

Similar to Acute liver failure with hemolysis

Pediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptxPediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptx
Ibrahim Sandokji
 
Indirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemiaIndirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemiaSanjeev Kumar
 
Paediatric Acute Liver Failure
Paediatric Acute Liver FailurePaediatric Acute Liver Failure
Paediatric Acute Liver Failure
farahkhan952253
 
Clinical Case Study
Clinical Case StudyClinical Case Study
Clinical Case Study
Ashley Hamilton
 
NSAID induced AKI in pediatrics ((case))
NSAID induced AKI in pediatrics ((case))NSAID induced AKI in pediatrics ((case))
NSAID induced AKI in pediatrics ((case))
A198900
 
Hyperoxaluria case presentation
Hyperoxaluria case presentationHyperoxaluria case presentation
Hyperoxaluria case presentationSanjeev Kumar
 
Anemia el-menyia
Anemia el-menyiaAnemia el-menyia
Anemia el-menyia
FarragBahbah
 
Case Hyponatremia
Case HyponatremiaCase Hyponatremia
Case Hyponatremia
Kuan Yu Chiang
 
Child with Lower GI Bleeding - Case Presentation
Child with Lower GI Bleeding - Case PresentationChild with Lower GI Bleeding - Case Presentation
Child with Lower GI Bleeding - Case Presentation
Fatima Farid
 
Janudice
JanudiceJanudice
Janudice
Zain Khan
 
HCC Presentation- Shampa (Corrected).pptx
HCC Presentation- Shampa (Corrected).pptxHCC Presentation- Shampa (Corrected).pptx
HCC Presentation- Shampa (Corrected).pptx
DrMajidulIslam
 
ACLF mortality1.pptx
ACLF mortality1.pptxACLF mortality1.pptx
ACLF mortality1.pptx
Ravi Ravi
 
Common drug induced liver injury in children -dr. harshad devarbhai
Common drug induced liver injury in children -dr.  harshad devarbhaiCommon drug induced liver injury in children -dr.  harshad devarbhai
Common drug induced liver injury in children -dr. harshad devarbhai
Sanjeev Kumar
 
Combined Clinic (Cirrhosis of Liver)
Combined Clinic (Cirrhosis of Liver)Combined Clinic (Cirrhosis of Liver)
Combined Clinic (Cirrhosis of Liver)
Kyaw San Lin
 
Case Study Presentation-Rachael Joseph
Case Study Presentation-Rachael JosephCase Study Presentation-Rachael Joseph
Case Study Presentation-Rachael JosephRachael Joseph
 
Management of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptxManagement of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptx
Ernest Osemudiamen Salami
 
A PRESENTATION ON DECOMPENSATED LIVER DX.pptx
A PRESENTATION ON DECOMPENSATED LIVER DX.pptxA PRESENTATION ON DECOMPENSATED LIVER DX.pptx
A PRESENTATION ON DECOMPENSATED LIVER DX.pptx
ArahimeHitsugayaHata
 

Similar to Acute liver failure with hemolysis (20)

Pediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptxPediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptx
 
Indirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemiaIndirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemia
 
Paediatric Acute Liver Failure
Paediatric Acute Liver FailurePaediatric Acute Liver Failure
Paediatric Acute Liver Failure
 
A Case of Atypical Hemolytic Uremic Syndrome
A Case of Atypical Hemolytic Uremic SyndromeA Case of Atypical Hemolytic Uremic Syndrome
A Case of Atypical Hemolytic Uremic Syndrome
 
Clinical Case Study
Clinical Case StudyClinical Case Study
Clinical Case Study
 
NSAID induced AKI in pediatrics ((case))
NSAID induced AKI in pediatrics ((case))NSAID induced AKI in pediatrics ((case))
NSAID induced AKI in pediatrics ((case))
 
Hyperoxaluria case presentation
Hyperoxaluria case presentationHyperoxaluria case presentation
Hyperoxaluria case presentation
 
Anemia el-menyia
Anemia el-menyiaAnemia el-menyia
Anemia el-menyia
 
Case Hyponatremia
Case HyponatremiaCase Hyponatremia
Case Hyponatremia
 
Child with Lower GI Bleeding - Case Presentation
Child with Lower GI Bleeding - Case PresentationChild with Lower GI Bleeding - Case Presentation
Child with Lower GI Bleeding - Case Presentation
 
Janudice
JanudiceJanudice
Janudice
 
Grapes and Raisins
Grapes and RaisinsGrapes and Raisins
Grapes and Raisins
 
HCC Presentation- Shampa (Corrected).pptx
HCC Presentation- Shampa (Corrected).pptxHCC Presentation- Shampa (Corrected).pptx
HCC Presentation- Shampa (Corrected).pptx
 
ACLF mortality1.pptx
ACLF mortality1.pptxACLF mortality1.pptx
ACLF mortality1.pptx
 
Common drug induced liver injury in children -dr. harshad devarbhai
Common drug induced liver injury in children -dr.  harshad devarbhaiCommon drug induced liver injury in children -dr.  harshad devarbhai
Common drug induced liver injury in children -dr. harshad devarbhai
 
Combined Clinic (Cirrhosis of Liver)
Combined Clinic (Cirrhosis of Liver)Combined Clinic (Cirrhosis of Liver)
Combined Clinic (Cirrhosis of Liver)
 
ppt
pptppt
ppt
 
Case Study Presentation-Rachael Joseph
Case Study Presentation-Rachael JosephCase Study Presentation-Rachael Joseph
Case Study Presentation-Rachael Joseph
 
Management of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptxManagement of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptx
 
A PRESENTATION ON DECOMPENSATED LIVER DX.pptx
A PRESENTATION ON DECOMPENSATED LIVER DX.pptxA PRESENTATION ON DECOMPENSATED LIVER DX.pptx
A PRESENTATION ON DECOMPENSATED LIVER DX.pptx
 

More from Sanjeev Kumar

6 year old with resistant rickets
6 year old with resistant rickets6 year old with resistant rickets
6 year old with resistant rickets
Sanjeev Kumar
 
Role of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr BanumathiRole of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr Banumathi
Sanjeev Kumar
 
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John MatthaiHepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Sanjeev Kumar
 
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Sanjeev Kumar
 
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish BavdekarChoice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
Sanjeev Kumar
 
Copper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas SankaranarayananCopper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas Sankaranarayanan
Sanjeev Kumar
 
Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?
Sanjeev Kumar
 
Complications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi SathiyasekaranComplications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi Sathiyasekaran
Sanjeev Kumar
 
How do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini MridulaHow do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini Mridula
Sanjeev Kumar
 
Wilsons disease and hepatitis dr. abhamoni baro
Wilsons disease and hepatitis  dr. abhamoni baroWilsons disease and hepatitis  dr. abhamoni baro
Wilsons disease and hepatitis dr. abhamoni baro
Sanjeev Kumar
 
Acute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhalAcute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhal
Sanjeev Kumar
 
Child with acute liver failure dr. kirtichandra kodali
Child with acute liver failure dr.  kirtichandra kodaliChild with acute liver failure dr.  kirtichandra kodali
Child with acute liver failure dr. kirtichandra kodali
Sanjeev Kumar
 
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meenaHepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Sanjeev Kumar
 
Systemic illness with hepatitis dr ambreen pandrowala
Systemic illness with hepatitis dr ambreen pandrowalaSystemic illness with hepatitis dr ambreen pandrowala
Systemic illness with hepatitis dr ambreen pandrowala
Sanjeev Kumar
 
Thalassemia major with hepatitis c dr. ramya h n
Thalassemia major with hepatitis c   dr. ramya h nThalassemia major with hepatitis c   dr. ramya h n
Thalassemia major with hepatitis c dr. ramya h n
Sanjeev Kumar
 
Persistent jaundice a neonate dr. moinak sen sarma
Persistent jaundice a neonate  dr. moinak sen sarmaPersistent jaundice a neonate  dr. moinak sen sarma
Persistent jaundice a neonate dr. moinak sen sarma
Sanjeev Kumar
 
15 month child with fatty liver dr. bikrant bihari lal
15 month child with fatty liver  dr.  bikrant bihari lal15 month child with fatty liver  dr.  bikrant bihari lal
15 month child with fatty liver dr. bikrant bihari lal
Sanjeev Kumar
 
11 yr old with a fatty liver dr. shilpa hegde
11 yr old with a fatty liver  dr. shilpa hegde11 yr old with a fatty liver  dr. shilpa hegde
11 yr old with a fatty liver dr. shilpa hegde
Sanjeev Kumar
 
Hbs ag positive in special situation dr. prarthana kalgaonkar
Hbs ag positive in special situation   dr. prarthana kalgaonkarHbs ag positive in special situation   dr. prarthana kalgaonkar
Hbs ag positive in special situation dr. prarthana kalgaonkarSanjeev Kumar
 
Hepatitis in an hiv positive child dr. radhika kalekar
Hepatitis in an hiv positive child dr. radhika kalekarHepatitis in an hiv positive child dr. radhika kalekar
Hepatitis in an hiv positive child dr. radhika kalekar
Sanjeev Kumar
 

More from Sanjeev Kumar (20)

6 year old with resistant rickets
6 year old with resistant rickets6 year old with resistant rickets
6 year old with resistant rickets
 
Role of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr BanumathiRole of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr Banumathi
 
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John MatthaiHepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
 
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
 
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish BavdekarChoice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
 
Copper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas SankaranarayananCopper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas Sankaranarayanan
 
Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?
 
Complications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi SathiyasekaranComplications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi Sathiyasekaran
 
How do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini MridulaHow do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini Mridula
 
Wilsons disease and hepatitis dr. abhamoni baro
Wilsons disease and hepatitis  dr. abhamoni baroWilsons disease and hepatitis  dr. abhamoni baro
Wilsons disease and hepatitis dr. abhamoni baro
 
Acute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhalAcute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhal
 
Child with acute liver failure dr. kirtichandra kodali
Child with acute liver failure dr.  kirtichandra kodaliChild with acute liver failure dr.  kirtichandra kodali
Child with acute liver failure dr. kirtichandra kodali
 
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meenaHepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
 
Systemic illness with hepatitis dr ambreen pandrowala
Systemic illness with hepatitis dr ambreen pandrowalaSystemic illness with hepatitis dr ambreen pandrowala
Systemic illness with hepatitis dr ambreen pandrowala
 
Thalassemia major with hepatitis c dr. ramya h n
Thalassemia major with hepatitis c   dr. ramya h nThalassemia major with hepatitis c   dr. ramya h n
Thalassemia major with hepatitis c dr. ramya h n
 
Persistent jaundice a neonate dr. moinak sen sarma
Persistent jaundice a neonate  dr. moinak sen sarmaPersistent jaundice a neonate  dr. moinak sen sarma
Persistent jaundice a neonate dr. moinak sen sarma
 
15 month child with fatty liver dr. bikrant bihari lal
15 month child with fatty liver  dr.  bikrant bihari lal15 month child with fatty liver  dr.  bikrant bihari lal
15 month child with fatty liver dr. bikrant bihari lal
 
11 yr old with a fatty liver dr. shilpa hegde
11 yr old with a fatty liver  dr. shilpa hegde11 yr old with a fatty liver  dr. shilpa hegde
11 yr old with a fatty liver dr. shilpa hegde
 
Hbs ag positive in special situation dr. prarthana kalgaonkar
Hbs ag positive in special situation   dr. prarthana kalgaonkarHbs ag positive in special situation   dr. prarthana kalgaonkar
Hbs ag positive in special situation dr. prarthana kalgaonkar
 
Hepatitis in an hiv positive child dr. radhika kalekar
Hepatitis in an hiv positive child dr. radhika kalekarHepatitis in an hiv positive child dr. radhika kalekar
Hepatitis in an hiv positive child dr. radhika kalekar
 

Recently uploaded

Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 

Recently uploaded (20)

Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 

Acute liver failure with hemolysis

  • 1. Presenter : Ravi Bhardwaj Moderator: Anupam Sibal Panelists : BR Thapa, Harshad Devarbhavi, RK Dhiman, Srinivas Sankaranarayanan Case Discussion Acute liver failure with hemolysis – needing a transplant
  • 2. Dr Ravi Bharadwaj FNB Pediatric Gastroenterology Apollo Center For Advanced Pediatrics Indraprastha Apollo Hospital
  • 3. Presenting complaints 10 year old Female Presented in June 2016 with c/o: Poor appetite with nausea Fatigability Progressive abdominal distension Symptoms for 4 weeks Took medicines from nearby practitioner
  • 4. 5th week of illness Two episode of cola colored urine painless A day later parents noticed yellowish discoloration of eyes Decreased urine output
  • 5. No documented fever No diarrhea/abdominal pain/vomiting No skin lesions/joint pain/joint swelling/chest pain No dysuria/edema/pustules No significant drug history No bleeding from any site (skin, GI) No seizures/alteration in sensorium/abnormal movements/behavioural changes
  • 7. Past History No history of blood transfusion No similar history in past No history of prior admission for any illness
  • 8. Developmentally normal Vaccinated for age Family history One younger male sibling – 7 years, well no history of similar illness in family No h/o consanguinity Dietary history: Calories 90 Cal/kg/day Protein 1.5 g/kg/day
  • 9. Admitted in nearby hospital Evaluated and referred for further evaluation
  • 10. On examination RR: 26/min Pulse: 96/min Temp: 98.3 F BP: 116/70mm Hg SPO2: 96% Weight: 25 kg (-1 to -2 SD) Height: 128 cms ( -1 to -2 SD )
  • 11. Pallor +, Icterus + No clubbing/spider nevi/palmar erythema Periorbital puffiness + P/A: distended, soft Liver 2 cms BCM/span 10 cms, firm with sharp margins Spleen 2 cms BCM, firm FF+ CVS – WNL Chest – no added sounds CNS – WNL
  • 13. Question? How should this child be investigated further?
  • 14. Investigations Investigations Hb 8.3 Bil T/D 19.6/10.2 TLC 13100 P32L63 AST/ALT 670/214 Platelet count 113000 GGT 42 Peripheral smear normocytes, few schistocytes Fragmented RBC’s ALP 47 ESR 21 mm/hr Prot/Albumin 7.3/3.5 Retic count 7% (corrected) PT/INR 3.7 DCT negative BU/Cr 54/1.1 Urine R/M Positive for Hb Protein 1 + Uric acid 1.1 LDH 886 Cultures sterile USG abdomen Coarse liver, spleen enlarged, mild ascites
  • 15. Investigations Anti-HAV IgM and total NR HBsAg NR Anti-HCV NR Ceruloplasmin 8 mg/dl 24 Hr Urinary Copper (without challenge) 413 mcg/day KF ring positive ANA negative
  • 16.
  • 17.
  • 18. Score 7 on WD criteria (Leipzig score) by Ferenci et al Serum Cp <10 mg/dl +2 Urine Cu > 2 ULN +2 KF ring +2 Coomb’s negative hemolytic anemia +1 Wilson's disease ( score > 4)
  • 19. Acute Liver Failure in WD Modest rises in serum aminotransferases (<< 2000 IU/L) Normal or markedly subnormal SAP AST/ALT >2.2 and ALP/Bil <4 Coombs (–) hemolytic anemia and hemolysis Rapid progression to renal failure Korman J et al. Hepatology 2008 Ferenci et al. Aliment Pharmacol Ther 2004 Roberts et al. AASLD. Hepatology 2008 EASL. J Hepatol 2012
  • 20. D3 of admission developed altered sensorium drowsy hyperreflexia
  • 21. Question? Is the diagnosis of Wilson’s disease confirmed?
  • 22. Acute liver failure with grade 2 encephalopathy with coombs negative hemolysis with AKI Wilson’s disease
  • 24. ALF without encephalopathy Modified Nazer score New wilson’s index ? PELD/MELD Devarbhavi H et al. J Gastro Hepatol 2014
  • 25. Nazer score Nazer et al. Gut 1986
  • 26. Score Bilirubin ɥmol/L INR AST IU/L WCC x 109/L Albumin g/L 0 0-100 0-1.29 0-100 0-6.7 >45 1 101-150 1.3-1.6 101-150 6.8-8.3 34-44 2 151-200 1.7-1.9 151-300 8.4-10.3 25-33 3 201-300 2.0-2.4 301-400 10.4-15.3 21-24 4 >301 >2.5 >401 >15.4 <20 Modified King’s score (New Wilson Index) A score ≥ 11 urgent need for transplantation Our patient had a score of 16 Dhawan et al. Liver Transpl 2005
  • 27.
  • 28. Multivariate analysis Unadjusted hazard 95% Confidence P Ratio Interval Value Enc 2.88 1.11 – 7.45 .03 T Bil 1.05 1.02 – 1.09 .002 Only encepaholopaty and total bilirubin emerged as independent predictors of mortality
  • 29. Devarbhavi H. J Gastro Hepatol 2014 Score = 2.87 x encephalopathy + 1.07 x t bilirubin
  • 30. ALF with encephalopathy High mortality 80% (90% to 100% in some series) Liver transplantation is lifesaving Berman et al. Gastroenterology 1991 Roberts et al. AASLD. Hepatology 2008 EASL. J Hepatol 2012 Devarbhavi H et al. J Gastro Hepatol 2014
  • 31. Question? Treatment options in Wilsonian acute liver failure?
  • 32. Child was taken for LRLT Mother was donor
  • 34. Sibling evaluation First-degree relatives of any patient newly diagnosed with WD must be screened Chance of a sibling being a homozygote and therefore developing clinical disease – is 25% Analysis of the ATP7B gene for mutations in the children Roberts et al. AASLD. Hepatology 2008 EASL. J Hepatol 2012
  • 35. POD # 1 post LT on POD#1 sensorium improved over the next 72 hours
  • 36. Investigations Hb 7.9 TLC 8100 P52L43 Platelet count 87000 Bil T/D 5.6/3.2 AST/ALT 220/114 ALP 83 Prot/Albumin 6.1/2.9 PT/INR 1.3 BU/Cr 21/0.6 POD#4
  • 37. Child discharged on POD #19 On tacrolimus, MMF and prednisolone No acute post-LT complications Steroids tapered and stopped by 3 months
  • 38. Question? Role of supportive therapy, plasmapheresis, hemodialysis and MARS
  • 39. Neuro Wilson Less common in children < 10 years old: neuro-psychiatric disorders 17% Average age of neurological dysfunction is 18.9 years In adults neurological dysfunction constitutes initial clinical manifestation in 40–60% Pfeiffer et al. Semin Neurol. 2007
  • 40. LT in treatment of progressive neurological deterioration is controversial Pfeiffer et al. Semin Neurol. 2007
  • 41. Question Role of LT in neuro Wilson?
  • 42. Post LT outcome Indication N/% Survival @1 year 5 year 10 year 15 year EHBA 66.1% 91.3 89.5 86.9 84.8 ALF 72.6 69 67 67 WD: Japan 2.6% 98.3 96.5 94.4 73.4 UNOS 90 89 SPLIT 96 91.4 France 89% 87% 87% 87% Arnon et al. Clin Transplant. 2011 Kasahara et al. Am J of Transpl 2013 Guillaud et al. J Hepatol. 2014
  • 43. LT experience Pediatric 220 BA 81 Metabolic liver diseases 54 Cryptogenic 34 ALF 19 BCS 08 NNH 06 AIH 03 Hep B 03 Hyper oxaluria 02* Poisoning 02 Hepatoblastoma 02 PVT 01** Hep C 01 HCC 01 Chronic rejection 01 * combined LK ** re transplant
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.